0000904454-05-000098.txt : 20120725 0000904454-05-000098.hdr.sgml : 20120725 20050208161454 ACCESSION NUMBER: 0000904454-05-000098 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050208 DATE AS OF CHANGE: 20050208 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BARRIER THERAPEUTICS INC CENTRAL INDEX KEY: 0001173657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223828030 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-79875 FILM NUMBER: 05584207 BUSINESS ADDRESS: STREET 1: 600 COLLEGE ROAD EAST STREET 2: SUITE 3200 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 6099451200 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0103 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 7325242454 SC 13G 1 s13g_0208-05barrier.txt SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ----------------- SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. )1 Barrier Therapeutics, Inc. ------------------------------------------------------------------------------ (Name of Issuer) Common Stock, $.0001 par value ------------------------------------------------------------------------------ (Title of Class of Securities) 06850R 10 8 ------------------------------------------------------------------------------ (CUSIP Number) April 28, 2004 ----------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) -------- 1 The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. CUSIP No. 06850R 10 8 Page 2 of 8 Pages -------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Johnson & Johnson 22-1024240 -------------------------------- 2. CHECK THE APPROPRIATE BOX IF (a) [ ] A MEMBER OF A GROUP (b) [ ] -------------------------------- 3. SEC USE ONLY -------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION New Jersey -------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES BENEFICIALLY -0- OWNED BY EACH 6. SHARED VOTING POWER REPORTING PERSON WITH 4,448,076 shares of Common Stock ------------------------------------------ 7. SOLE DISPOSITIVE POWER -0- ------------------------------------------ 8. SHARED DISPOSITIVE POWER 4,448,076 shares of Common Stock -------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,448,076 shares of Common Stock -------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] -------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 20.36% -------------------------------- 12. TYPE OF REPORTING PERSON CO -------------------------------- CUSIP No. 06850R 10 8 Page 3 of 8 Pages -------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Johnson & Johnson Consumer Companies, Inc. -------------------------------- 2. CHECK THE APPROPRIATE BOX IF (a) [ ] A MEMBER OF A GROUP (b) [ ] -------------------------------- 3. SEC USE ONLY -------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware -------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES BENEFICIALLY -0- OWNED BY EACH 6. SHARED VOTING POWER REPORTING PERSON 1,016,666 shares of Common Stock WITH ------------------------------------------- 7. SOLE DISPOSITIVE POWER -0- ------------------------------------------- 8. SHARED DISPOSITIVE POWER 1,016,666 shares of Common Stock -------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,016,666 shares of Common Stock -------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] -------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.7% -------------------------------- 12. TYPE OF REPORTING PERSON CO -------------------------------- CUSIP No. 06850R 10 8 Page 4 of 8 Pages 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Johnson & Johnson Development Corporation 22-2007137 -------------------------------- 2. CHECK THE APPROPRIATE BOX IF (a) [ ] A MEMBER OF A GROUP (b) [ ] -------------------------------- 3. SEC USE ONLY -------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION New Jersey -------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES BENEFICIALLY -0- OWNED BY EACH 6. SHARED VOTING POWER REPORTING PERSON 281,410 shares of Common Stock WITH ------------------------------------------ 7. SOLE DISPOSITIVE POWER -0- ------------------------------------------ 8. SHARED DISPOSITIVE POWER 281,410 shares of Common Stock -------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 281,410 shares of Common Stock -------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] -------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.3% -------------------------------- 12. TYPE OF REPORTING PERSON CO -------------------------------- CUSIP No. 06850R 10 8 Page 5 of 8 Pages 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Janssen Pharmaceutica Products, L.P. -------------------------------- 2. CHECK THE APPROPRIATE BOX IF (a) [ ] A MEMBER OF A GROUP (b) [ ] -------------------------------- 3. SEC USE ONLY -------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware -------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES BENEFICIALLY -0- OWNED BY EACH 6. SHARED VOTING POWER REPORTING PERSON 3,150,000 shares of Common Stock WITH ------------------------------------------ 7. SOLE DISPOSITIVE POWER -0- ------------------------------------------ 8. SHARED DISPOSITIVE POWER 3,150,000 shares of Common Stock -------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,150,000 shares of Common Stock -------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] -------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 14.4% -------------------------------- 12. TYPE OF REPORTING PERSON PN -------------------------------- CUSIP No. 06850R 10 8 Page 6 of 8 Pages Schedule 13G ------------ ITEM 1(a) - NAME OF ISSUER: Barrier Therapeutics, Inc. ITEM 1(b) - ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 600 College Road East Suite 3200 Princeton, NJ 08540 ITEM 2(a) - NAME OF PERSON FILING: This statement is being filed by Johnson & Johnson, a New Jersey corporation ("J&J"), Johnson & Johnson Development Corporation, a New Jersey corporation ("JJDC"), Janssen Pharmaceutica Products, L.P., a Delaware limited partnership ("JPP"), and Johnson & Johnson Consumer Companies, Inc., a Delaware corporation ("JJCC"). JJDC, JPP and JJCC are wholly-owned subsidiaries of J&J. The securities reported herein as being held by J&J, JJDC, JPP and JJCC are directly beneficially owned by JJDC, JPP and JJCC. J&J may be deemed to indirectly beneficially own the securities that are directly beneficially owned by JJDC, JPP and JJCC. ITEM 2(b) - ADDRESS OF PRINCIPAL BUSINESS OFFICE: One Johnson & Johnson Plaza New Brunswick, NJ 08933 ITEM 2(c) - CITIZENSHIP: J&J: New Jersey JJDC: New Jersey JPP: Delaware JJCC: Delaware ITEM 2(d) - TITLE OF CLASS OF SECURITIES: Common Stock, $.0001 par value per share ("Common Stock") ITEM 2(e) - CUSIP NUMBER: 06850R 10 8 ITEM 3 - STATEMENTS FILED PURSUANT TO RULES 13D-1(B) OR 13D-2(B) OR (C): Not applicable. ITEM 4 - OWNERSHIP: (a) Amount Beneficially Owned: J&J: 4,448,076 shares of Common Stock JJDC: 281,410 shares of Common Stock JPP: 3,150,000 shares of Common Stock JJCC: 1,016,666 shares of Common Stock CUSIP No. 06850R 10 8 Page 7 of 8 Pages (b) Percent of Class: J&J: 20.36% JJDC: 1.3% JPP: 14.4% JJCC: 4.7% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: -0- (ii) shared power to vote or to direct the vote: J&J: 4,448,076 shares of Common Stock JJDC: 281,410 shares of Common Stock JPP: 3,150,000 shares of Common Stock JJCC: 1,016,666 shares of Common Stock (iii) sole power to dispose or to direct the disposition of: -0- (iv) shared power to dispose or to direct the disposition of: J&J: 4,448,076 shares of Common Stock JJDC: 281,410 shares of Common Stock JPP: 3,150,000 shares of Common Stock JJCC: 1,016,666 shares of Common Stock ITEM 5 - OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: Not applicable. ITEM 6 - OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not applicable. ITEM 7 - IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT COMPANY: Not applicable. ITEM 8 - IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Not applicable. ITEM 9 - NOTICE OF DISSOLUTION OF GROUP: Not applicable. ITEM 10 - CERTIFICATION: Not applicable. CUSIP No. 06850R 10 8 Page 8 of 8 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. JOHNSON & JOHNSON By /s/ MICHAEL H. ULLMANN ---------------------- Name: Michael H. Ullmann Title: Secretary JOHNSON & JOHNSON DEVELOPMENT CORPORATION By /s/ MANISH YADAV ---------------- Name: Manish Yadav Title: Secretary JANSSEN PHARMACEUTICA, L.P. By Janssen Pharmaceutica, Inc., General Partner By /s/ MIKE C. CHESTER -------------------- Name: Mike C. Chester Title: Secretary JOHNSON & JOHNSON CONSUMER COMPANIES, INC. By /s/ DONNA M. MALIN ------------------ Name: Donna M. Malin Title: Secretary Dated: February 1, 2005